Real Time Insider Transaction Data

Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data

Selection Criteria
Timeframe :
or : Date range    From:    To:


Minimum transaction amount: $
Symbol watch list: (max. 15)
Total Transactions Amount
Buys 0 $0
Sells 33 $754,597
Date Time ET
Symbol
Security Reporting Name Relationship
Trans. Date
Purchase/Sale Shares Price $
Amount $
D/I
02 Jan 19:18 RPTP Raptor Pharmaceutical Corp STARR CHRISTOPHER M Chief Executive Officer 31 Dec 2012 Sale 10,088 5.68 57,300 D
31 Dec 13:42 RPTP Raptor Pharmaceutical Corp ANDERSON RAYMOND Director 28 Dec 2012 Sale 2,000 5.5 11,000 D
18 Dec 21:23 RPTP Raptor Pharmaceutical Corp SAGER ERICH Director 17 Dec 2012 Sale 10,984 5.43 59,643 D
18 Dec 21:23 RPTP Raptor Pharmaceutical Corp SAGER ERICH Director 17 Dec 2012 Sale 3,924 5.35 20,993 D
18 Dec 16:33 RPTP Raptor Pharmaceutical Corp DALEY THOMAS E President, Raptor Therapeutics 17 Dec 2012 Sale 3,333 5.45 18,165 D
28 Nov 21:24 RPTP Raptor Pharmaceutical Corp SAGER ERICH Director 27 Nov 2012 Sale 3,629 5 18,145 D
27 Nov 17:33 RPTP Raptor Pharmaceutical Corp KELTNER LLEW Director 26 Nov 2012 Sale 969 5 4,845 D
27 Nov 17:25 RPTP Raptor Pharmaceutical Corp SAGER ERICH Director 26 Nov 2012 Sale 11,279 5 56,395 D
17 Oct 14:01 RPTP Raptor Pharmaceutical Corp DALEY THOMAS E President, Raptor Therapeutics 15 Oct 2012 Sale 3,333 5.22 17,398 D
01 Oct 17:31 RPTP Raptor Pharmaceutical Corp ANDERSON RAYMOND Director 01 Oct 2012 Sale 2,000 5.58 11,160 D
01 Oct 14:19 RPTP Raptor Pharmaceutical Corp STARR CHRISTOPHER M Chief Executive Officer 28 Sep 2012 Sale 10,085 5.39 54,358 D
18 Sep 18:32 RPTP Raptor Pharmaceutical Corp SAGER ERICH Director 17 Sep 2012 Sale 14,908 5.4084 80,629 D
18 Sep 18:29 RPTP Raptor Pharmaceutical Corp KELTNER LLEW Director 17 Sep 2012 Sale 967 5.49 5,309 D
14 Sep 19:23 RPTP Raptor Pharmaceutical Corp ANDERSON RAYMOND Director 12 Sep 2012 Sale 2,000 5.5 11,000 D
05 Sep 14:21 RPTP Raptor Pharmaceutical Corp ZANKEL TODD Chief Scientific Officer 04 Sep 2012 Sale 842 5 4,210 D
04 Sep 15:45 RPTP Raptor Pharmaceutical Corp ZANKEL TODD Chief Scientific Officer 30 Aug 2012 Sale 2,648 5 13,240 D
04 Sep 15:45 RPTP Raptor Pharmaceutical Corp ZANKEL TODD Chief Scientific Officer 31 Aug 2012 Sale 7,500 5 37,500 D
04 Sep 14:51 RPTP Raptor Pharmaceutical Corp SAGER ERICH Director 30 Aug 2012 Sale 2,700 5 13,500 D
04 Sep 14:51 RPTP Raptor Pharmaceutical Corp SAGER ERICH Director 31 Aug 2012 Sale 5,000 5 25,000 D
31 Aug 18:29 RPTP Raptor Pharmaceutical Corp TSUCHIMOTO KIM R Chief Financial Officer 29 Aug 2012 Sale 3,510 5 17,550 D
31 Aug 16:28 RPTP Raptor Pharmaceutical Corp ZANKEL TODD Chief Scientific Officer 29 Aug 2012 Sale 10,136 5.01 50,781 D
31 Aug 14:26 RPTP Raptor Pharmaceutical Corp SAGER ERICH Director 29 Aug 2012 Sale 3,284 5.01 16,453 D
29 Aug 21:46 RPTP Raptor Pharmaceutical Corp ZANKEL TODD Chief Scientific Officer 27 Aug 2012 Sale 287 5 1,435 D
29 Aug 21:37 RPTP Raptor Pharmaceutical Corp DALEY THOMAS E President, Raptor Therapeutics 27 Aug 2012 Sale 3,333 5 16,665 D
29 Aug 21:34 RPTP Raptor Pharmaceutical Corp SAGER ERICH Director 27 Aug 2012 Sale 3,808 5 19,040 D
29 Aug 21:06 RPTP Raptor Pharmaceutical Corp TSUCHIMOTO KIM R Chief Financial Officer 27 Aug 2012 Sale 49 5 245 D
02 Aug 16:24 RPTP Raptor Pharmaceutical Corp SAGER ERICH Director 01 Aug 2012 Sale 116 5 580 D
02 Aug 16:08 RPTP Raptor Pharmaceutical Corp KELTNER LLEW Director 01 Aug 2012 Sale 967 5 4,835 D
02 Jul 19:26 RPTP Raptor Pharmaceutical Corp STARR CHRISTOPHER M Chief Executive Officer 29 Jun 2012 Sale 10,085 5.5997 56,473 D
18 Jun 17:52 RPTP Raptor Pharmaceutical Corp DALEY THOMAS E President, Raptor Therapeutics 15 Jun 2012 Sale 3,333 5.7669 19,221 D
18 Jun 15:00 RPTP Raptor Pharmaceutical Corp TSUCHIMOTO KIM R Chief Financial Officer 15 Jun 2012 Sale 3,559 5.7681 20,529 D
11 Jun 15:32 RPTP Raptor Pharmaceutical Corp ANDERSON RAYMOND Director 08 Jun 2012 Sale 1,965 5.5 10,808 D
11 Jun 15:28 RPTP Raptor Pharmaceutical Corp ANDERSON RAYMOND Director 07 Jun 2012 Sale 35 5.5 192 D

* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)